Advisory
Groups
TRIDENT is counselled using a horizontal, consensus-driven management structure to promote trans- and interdisciplinary practices.
TRIDENT
Executive Committee
The TRIDENT Executive Committee (TEC), comprised of one representative from each of the platform Research Cores, oversees key decision making and manages operational aspects of the platform.
TEC Members
Dr. Tom Durcan
​​Associate Professor, Department of Neurology and Neurosurgery,
McGill University
Dr. Ravi Menon​​
​Professor, Departments of Medical Biophysics, Medical Imaging, Neuroscience, and Psychiatry, Western University
​Dr. Stefan Everling
​Professor of Physiology and Pharmacology, Western University
Dr. Marco Prado
Professor, Department of Physiology and
Pharmacology and Department of Anatomy
& Cell Biology, Western University
Dr. Liisa Galea
​Professor, Departments of Psychiatry, and Pharmacology and Toxicology,
University of Toronto
​Dr. Jane Rylett
​Scientific Director
CIHR Institute of Aging​
Dr. Richard Gold
Professor, Faculty of Law, McGill University
​Dr. Lisa Saksida
​Professor, Physiology and Pharmacology
The Schulich School of Medicine & Dentistry, Western University​
Knowledge
Exchange Group
The TRIDENT Knowledge Exchange Group (KEG) serves as the overall collaborative knowledge exchange venue for all members of the TRIDENT platform.
InTEP
The Interdisciplinary Therapeutic Evaluation Panel (InTEP) serves as an impartial committee to review pre-clinical evidence at key decision points during the evaluation process,
and makes recommendations regarding which neurotherapeutics should enter the TRIDENT pipeline, as well as advance within the pipeline.
TRIDENT
ADVISORY
COUNCIL
The TRIDENT Advisory Council (TAC) reviews all activities related to the project and provides recommendations as to the best approaches to ensure its success as an innovative platform that meets the requirement of the population it helps. The TAC also provide strategic insights on the direction of TRIDENT’s research, policies, knowledge mobilization activities, and public/private partnership strategies.
​
​
TAC Members
Dr. Lynn Beattie
Director & President
CLEAR ​​
​
​Dr. David Lee
Chief Regulatory Officer
Health Canada
​​
​Dr. Mira Puri
Manager, Science Initiatives
Azreili Foundation
​
Dr. Samuel Chuang
Senior Director, Scientific Advisory Services
Charles River Laboratories
Dr. Karen Lee
President & CEO
Parkinson Canada
​
​Dr. Jane Rylett
Manager, Science Initiatives
Azreili Foundation
​
Heather Innes
Community Engagement Coordinator
Parkinson Society SW Ontario
Dr. Ariel Louwrier
President and CEO
Stressmarq Biosciences
​